一例5-羟色胺再摄取抑制剂诱发的不可逆性帕金森症病例。
A Case of SSRI Induced Irreversible Parkinsonism.
作者信息
Dixit Siddharth, Khan Shahbaj A, Azad Sudip
机构信息
Classified Specialist, Department of Psychiatry, Base Hospital Delhi Cantt , New Delhi, India .
Resident, Department of Psychiatry, Base Hospital Delhi Cantt , New Delhi, India .
出版信息
J Clin Diagn Res. 2015 Feb;9(2):VD01-VD02. doi: 10.7860/JCDR/2015/11394.5583. Epub 2015 Feb 1.
Abstract
Serotonin specific reuptake inhibitors (SSRI) are widely used antidepressants for variety of clinical conditions and have found popularity. They are sometimes associated with extrapyramidal side effects including Parkinsonism. We report a case of generalized anxiety disorder on treatment with SSRI (fluoxetine / sertraline) who developed irreversible Parkinsonism. SSRI are known to cause reversible or irreversible motor disturbances through pathophysiological changes in basal ganglion motor system by altering the dopamine receptors postsynaptically. Clinician should keep risk benefit ratio in mind and change of antidepressant of different class may be considered. Case is reported to alert physicians to possibility of motor system damage while treating with SSRI.
摘要
血清素特异性再摄取抑制剂（SSRI）是广泛用于治疗各种临床病症的抗抑郁药，且颇受欢迎。它们有时会伴有锥体外系副作用，包括帕金森症。我们报告一例接受SSRI（氟西汀/舍曲林）治疗的广泛性焦虑症患者，该患者出现了不可逆的帕金森症。已知SSRI通过改变基底神经节运动系统的多巴胺受体突触后病理生理变化，导致可逆或不可逆的运动障碍。临床医生应牢记风险效益比，并可考虑更换不同类别的抗抑郁药。报告此病例是为了提醒医生在使用SSRI治疗时注意运动系统受损的可能性。
相似文献
1
A Case of SSRI Induced Irreversible Parkinsonism.一例5-羟色胺再摄取抑制剂诱发的不可逆性帕金森症病例。
J Clin Diagn Res. 2015 Feb;9(2):VD01-VD02. doi: 10.7860/JCDR/2015/11394.5583. Epub 2015 Feb 1.
2
Hypobaric hypoxia exposure in rats differentially alters antidepressant efficacy of the selective serotonin reuptake inhibitors fluoxetine, paroxetine, escitalopram and sertraline.低压缺氧暴露会使选择性 5-羟色胺再摄取抑制剂氟西汀、帕罗西汀、艾司西酞普兰和舍曲林对大鼠的抗抑郁作用产生差异。
Pharmacol Biochem Behav. 2018 Jul;170:25-35. doi: 10.1016/j.pbb.2018.05.002. Epub 2018 May 5.
3
[Efficacy of atypical antipsychotics in depressive syndromes].非典型抗精神病药物在抑郁综合征中的疗效
Encephale. 2004 Nov-Dec;30(6):583-9. doi: 10.1016/s0013-7006(04)95474-7.
4
Movement disorders associated with the serotonin selective reuptake inhibitors.与血清素选择性再摄取抑制剂相关的运动障碍。
J Clin Psychiatry. 1996 Oct;57(10):449-54. doi: 10.4088/jcp.v57n1002.
5
[Selective serotonin reuptake inhibitors in major depressive disorder in children and adolescents (ratio of benefits/risks)].[儿童和青少年重度抑郁症中选择性5-羟色胺再摄取抑制剂（获益/风险比）]
Encephale. 2005 May-Jun;31(3):309-16. doi: 10.1016/s0013-7006(05)82395-4.
6
Similar effectiveness of paroxetine, fluoxetine, and sertraline in primary care: a randomized trial.帕罗西汀、氟西汀和舍曲林在初级保健中的疗效相似：一项随机试验。
JAMA. 2001 Dec 19;286(23):2947-55. doi: 10.1001/jama.286.23.2947.
7
Pharmacy and medical costs associated with switching between venlafaxine and SSRI antidepressant therapy for the treatment of major depressive disorder.文拉法辛与选择性5-羟色胺再摄取抑制剂（SSRI）抗抑郁治疗药物相互转换治疗重度抑郁症的药学及医疗成本。
J Manag Care Pharm. 2008 Jun;14(5):426-41. doi: 10.18553/jmcp.2008.14.5.426.
8
Anxiety-like effects induced by acute fluoxetine, sertraline or m-CPP treatment are reversed by pretreatment with the 5-HT2C receptor antagonist SB-242084 but not the 5-HT1A receptor antagonist WAY-100635.急性氟西汀、舍曲林或间氯苯哌嗪治疗所诱导的焦虑样效应，可被5-HT2C受体拮抗剂SB-242084预处理逆转，但不能被5-HT1A受体拮抗剂WAY-100635逆转。
Int J Neuropsychopharmacol. 2001 Dec;4(4):399-408. doi: 10.1017/S1461145701002632.
9
Selective serotonin reuptake inhibitor exposure.选择性5-羟色胺再摄取抑制剂暴露
Top Companion Anim Med. 2013 Feb;28(1):13-7. doi: 10.1053/j.tcam.2013.03.003.
10
"Dopamine-dependent" side effects of selective serotonin reuptake inhibitors: a clinical review.选择性5-羟色胺再摄取抑制剂的“多巴胺依赖型”副作用：一项临床综述
J Clin Psychiatry. 2004 Aug;65(8):1064-8. doi: 10.4088/jcp.v65n0806.
引用本文的文献
1
Serotonergic Medication Error: A Case Report of Serotonin Syndrome.血清素能药物错误：血清素综合征病例报告
Cureus. 2023 Nov 2;15(11):e48161. doi: 10.7759/cureus.48161. eCollection 2023 Nov.
2
Respecting the Patient's Choice: A Case of Possible Drug-Induced Parkinsonism.尊重患者的选择：一例疑似药物性帕金森综合征病例
Pharmacy (Basel). 2022 Jan 4;10(1):10. doi: 10.3390/pharmacy10010010.
3
Parkinsonism in the psychiatric setting: an update on clinical differentiation and management.精神科环境中的帕金森综合征：临床鉴别与管理的最新进展
BMJ Neurol Open. 2020 Jan 27;2(1):e000034. doi: 10.1136/bmjno-2019-000034. eCollection 2020.
4
Neuron-Astrocyte Interactions in Parkinson's Disease.神经元-星形胶质细胞在帕金森病中的相互作用。
Cells. 2020 Dec 7;9(12):2623. doi: 10.3390/cells9122623.
5
Escitalopram-induced extrapyramidal symptoms.艾司西酞普兰所致锥体外系症状。
Indian J Psychiatry. 2019 May-Jun;61(3):318-319. doi: 10.4103/psychiatry.IndianJPsychiatry_331_18.
6
Association of Parkinsonism or Parkinson Disease with Polypharmacy in the Year Preceding Diagnosis: A Nested Case-Control Study in South Korea.帕金森病或帕金森综合征与诊断前一年多药治疗的相关性：韩国一项嵌套病例对照研究。
Drug Saf. 2017 Nov;40(11):1109-1118. doi: 10.1007/s40264-017-0559-5.
7
Parkinsonism secondary to duloxetine use: a case report.度洛西汀所致帕金森综合征：一例报告
North Clin Istanb. 2015 Dec 25;2(3):243-246. doi: 10.14744/nci.2015.63634. eCollection 2015.
本文引用的文献
1
Extrapyramidal symptoms after Fluoxetine.氟西汀治疗后的锥体外系症状。
Med J Armed Forces India. 2015 Jul;71(Suppl 1):S99-S100. doi: 10.1016/j.mjafi.2013.05.002. Epub 2013 Aug 2.
2
Escitalopram-induced Parkinsonism.依地普仑诱发的帕金森病。
Gen Hosp Psychiatry. 2014 Jan-Feb;36(1):126.e1-2. doi: 10.1016/j.genhosppsych.2013.09.010. Epub 2013 Oct 5.
3
Drug-induced parkinsonism: a review of 17 years' experience in a regional pharmacovigilance center in France.药物性帕金森病：法国一个地区性药物警戒中心 17 年的经验回顾。
Mov Disord. 2011 Oct;26(12):2226-31. doi: 10.1002/mds.23828. Epub 2011 Jun 14.
4
Fluoxetine induced extrapyramidal symptoms : case reports.氟西汀引起的锥体外系症状：病例报告。
Indian J Psychiatry. 1998 Jan;40(1):87-9.
5
Citalopram-induced parkinsonian syndrome: case report.西酞普兰诱发的帕金森综合征：病例报告。
Clin Neuropharmacol. 2011 Mar-Apr;34(2):92-3. doi: 10.1097/WNF.0b013e318210ea3e.
6
Extrapyramidal symptoms associated with antidepressants--a review of the literature and an analysis of spontaneous reports.抗抑郁药相关的锥体外系症状——文献综述与自发报告分析
Ann Clin Psychiatry. 2010 Aug;22(3):148-56.
7
Drug-induced parkinsonism.
Handb Clin Neurol. 2007;84:399-416. doi: 10.1016/S0072-9752(07)84051-6.
8
Epidemiology of Parkinson's disease and movement disorders in India: problems and possibilities.印度帕金森病及运动障碍的流行病学：问题与前景
J Assoc Physicians India. 2007 Oct;55:719-24.
9
[123I]-FP/CIT SPECT imaging for distinguishing drug-induced parkinsonism from Parkinson's disease.[123I]-FP/CIT单光子发射计算机断层扫描成像用于区分药物性帕金森综合征与帕金森病。
Mov Disord. 2006 Apr;21(4):510-4. doi: 10.1002/mds.20748.
10
SSRIs do not worsen Parkinson's disease: evidence from an open-label, prospective study.选择性5-羟色胺再摄取抑制剂不会加重帕金森病：一项开放标签前瞻性研究的证据。
Clin Neuropharmacol. 2001 Jul-Aug;24(4):221-7. doi: 10.1097/00002826-200107000-00005.
Zotero 插件